Published in Int J Chron Obstruct Pulmon Dis on May 09, 2016
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J (2004) 16.84
Systemic manifestations and comorbidities of COPD. Eur Respir J (2009) 5.90
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study. Eur Respir J (2013) 4.65
St. George's Respiratory Questionnaire: MCID. COPD (2005) 3.99
Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax (2010) 3.06
Minimal clinically important differences in COPD lung function. COPD (2005) 3.00
Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med (2010) 2.80
Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD. Respir Med (2013) 2.75
Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med (2006) 1.76
Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study. Respir Med (2008) 1.55
Tiotropium + olodaterol shows clinically meaningful improvements in quality of life. Respir Med (2015) 1.17
Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis. Respir Res (2013) 1.12
Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis. Int J Chron Obstruct Pulmon Dis (2015) 0.84
Depression and heart failure associated with clinical COPD questionnaire outcome in primary care COPD patients: a cross-sectional study. NPJ Prim Care Respir Med (2014) 0.81